Diascreen Reagent Strips
FDA 510(k) K981555 · Chronimed, Inc.
510(k) numberK981555
Submission
- Device name
- Diascreen Reagent Strips
- Applicant
- Chronimed, Inc.
Edina, MN, US - Received
- May 1, 1998
- Decision date
- June 1, 1998
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LJX – Test, Urine Leukocyte
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 864.7675
- Specialty
- Hematology
Other 510(k)s with product code LJX
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K231045 | Healgen URS Test StripsLJX · Traditional | Healgen Scientific,, LLC | 06/16/2023SE |
| K063295 | Acon Uti Urinary Tract Infection Test StripsLJX · Traditional | ACON Laboratories, Inc. | 10/12/2007SE |
| K000578 | Serim Leukocyte Esterase Test StripsLJX · Traditional | Serim Research Corp. | 05/05/2000SE |
| K971976 | Diascreen Reagent StripsLJX · Traditional | Dia-Screen Corp. | 06/17/1997SE |
| K873304 | Clinitek Auto 2000 Reagent Cassette (Leukocytes)LJX · Traditional | Miles Laboratories, Inc. | 09/11/1987SE |
| K843727 | Leukostix Reagent Strips for UrinalysisLJX · Traditional | Miles Laboratories, Inc. | 01/04/1985SE |
More from Miles Laboratories, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K010039 | Quicktek Blood Glucose System, Quicktek Blood Glucose Meter, Quicktek Blood Glucose…NBW · Traditional | 08/10/2001SE |
| K983432 | Supreme II Control SolutionsJJX · Traditional | 12/17/1998SE |
| K980573 | Sensorex Blood Glucose Monitoring SystemCGA · Traditional | 07/30/1998SE |
| K963544 | Supreme II MeterCGA · Traditional | 02/20/1997SE |
Questions and answers
When was Diascreen Reagent Strips cleared by the FDA?
Diascreen Reagent Strips (K981555) received a 510(k) decision of Substantially Equivalent on June 1, 1998, 31 days after the submission was received.
What is the product code of K981555?
The FDA product code is LJX – Test, Urine Leukocyte, a Class I (low risk) device regulated under 21 CFR 864.7675.